Sector › Medicine

Press Releases

Eisai to Present New Lecanemab Data, Including Research Evaluating Safety Profile, Clinical Outcomes and Quality of Life Measures, as Well as Other Important Alzheimer's Disease Research, at the AD/PD 2023 Annual Meeting

Mar 23, 2023 12:30 HKT/SGT

エーザイ、第17回アルツハイマー・パーキンソン病学会（AD/PD 2023）において、レカネマブの安全性プロファイル、臨床結果、QOLの評価など、アルツハイマー病の研究に関する最新情報を発表

Mar 23, 2023 09:00 JST

Health-ISAC Releases Annual Report on Current and Emerging Cyber Threats to Healthcare

Mar 22, 2023 23:00 HKT/SGT

Health-ISAC Releases Annual Report on Current and Emerging Cyber Threats to Healthcare

Mar 22, 2023 23:00 HKT/SGT

With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers

Mar 21, 2023 19:00 HKT/SGT

Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing

Mar 21, 2023 08:30 HKT/SGT

Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing

Mar 21, 2023 08:00 HKT/SGT

Eisai Publishes Societal Value of Lecanemab Using Phase 3 Clarity AD Data in Peer-Reviewed Neurology and Therapy Journal

Mar 20, 2023 10:18 HKT/SGT

エーザイ、臨床第III相 Clarity AD 試験データを用いた「レカネマブ」の社会的価値について、査読学術専門誌 Neurology and Therapy 誌に掲載

Mar 20, 2023 10:00 JST

乐普生物公布2022年度业绩

Mar 17, 2023 23:01 HKT/SGT

樂普生物公佈2022年度業績

Mar 17, 2023 23:00 HKT/SGT

Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards

Mar 16, 2023 09:00 HKT/SGT

analytica Vietnam 2023: The Largest Gathering of Laboratory Technology, Analysis and Biotechnology Professionals in Southeast Asia

Mar 16, 2023 08:00 HKT/SGT

Amazfit Launches GTR Mini in Malaysia

Mar 15, 2023 19:00 HKT/SGT

Prenetics公布2022年第四季度及全年财务业绩新业务策略专注于精准肿瘤学

Mar 14, 2023 22:07 HKT/SGT

Prenetics公布2022年第四季度及全年財務業績新業務策略專注於精準腫瘤學

Mar 14, 2023 22:06 HKT/SGT

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology

Mar 14, 2023 22:05 HKT/SGT

U.S. Veterans' Health Administration (VHA) Provides Coverage of LEQEMBI (lecanemab-Irmb) Two Months After LEQEMBI's FDA Accelerated Approval for Veterans Living with Early Stages of Alzheimer's Disease

Mar 14, 2023 10:09 HKT/SGT

エーザイ、早期アルツハイマー病治療薬「LEQEMBI(TM)」（レカネマブ）について、米国退役軍人保健局が FDA による迅速承認から 2 カ月で保険適用を開始

Mar 14, 2023 09:30 JST

欧康维视获纳入沪港通及深港通名单

Mar 13, 2023 18:32 HKT/SGT